Convexia
PrivateLast Round
Seed
Jul 25, 2025
Total Funding Raised
$1M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Convexia is a healthcare company that provides an AI-driven platform for pharmaceutical drug discovery, asset sourcing, and clinical development.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Clinical Trials, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Convexia Comparables
Compare Convexia with similar companies based on industry and business-model similarity.
Convexia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 25, 2025 |
Convexia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Y Combinator | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 22, 2026
Grew 160% QoQ from 5 to 13 employees.
- Aug 21, 2026
Monthly visitors increased 45% MoM.
Convexia Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Convexia's valuation, stock price, and market status.
Is Convexia a public or private company?
Convexia is a private company.
What is the current stock price of Convexia?
Convexia is a private company, so its shares have no public market price. Caplight tracks Convexia's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Convexia worth (valuation)?
Valuation information for Convexia is not publicly available.
Can I buy Convexia stock?
Convexia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Convexia's last funding round?
Convexia's most recent funding round was Seed on July 25, 2025.
Who are the main investors in Convexia?
Key investors in Convexia include Y Combinator.
Will Convexia IPO soon?
No public IPO plans have been announced for Convexia.
How can I track Convexia secondary market activity?
Caplight tracks bids, offers, and trades in Convexia's shares on secondary markets.